Phosphodiesterase genes and antidepressant treatment response: a review.

Abstract excerpt

Depression results in a tremendous burden to individuals suffering from the disorder and to the global health economy. Available pharmacologic treatments for depression target monoamine levels and monoamine receptors. However, delayed onset of effect, partial or inadequate treatment response, and side-effects are significant limitations of current therapies. The search for a better understanding of mechanisms of...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Depression
• Share to Antidepressive Agents
• Share to Cyclic AMP